Spectrum of CREBBP gene dosage anomalies in Rubinstein-Taybi syndrome patients
- PMID: 17473832
- DOI: 10.1038/sj.ejhg.5201847
Spectrum of CREBBP gene dosage anomalies in Rubinstein-Taybi syndrome patients
Abstract
The Rubinstein-Taybi syndrome (RTS) is a rare autosomal-dominant disease associated with 10-15% of cases with 16p13.3 microdeletions involving the CREB-binding protein gene (CREBBP). We used array-comparative genomic hybridization and Quantitative multiplex fluorescent-PCR (QMF-PCR) to search for dosage anomalies in the 16p13.3 region and the CREBBP gene. We first constructed a microarray covering 2 Mb that carries seven BAC and 34 cosmid clones, as well as 26 low-molecular-weight probes (1000-1500 bp) that are spread along the CREBBP gene. To increase further the resolution inside the CREBBP gene, we used QMF-PCR assays providing a 7 kb resolution. The deletions characterized in this work extended between as little as 3.3 kb and 6.5 Mb. Some deletions were restricted to just a few exons of CREBBP, some deleted either the 5' or the 3' end of the gene plus adjacent genomic segments, others deleted the whole gene away. We also identified a duplication of exon 16. We showed that CREBBP dosage anomalies constitute a common cause of RTS. CREBBP high-resolution gene dosage search is therefore highly recommended for RTS diagnosis. No correlation was found between the type of deletion and the patients' phenotype. All patients had typical RTS, and there was no particular severity associated with certain alterations.
Similar articles
-
Cryptic microdeletion of the CREBBP gene from t(1;16) (p36.2;p13.3) as a novel genetic defect causing Rubinstein-Taybi syndrome.Ann Clin Lab Sci. 2013 Fall;43(4):450-6. Ann Clin Lab Sci. 2013. PMID: 24247805
-
Analysis of CBP (CREBBP) gene deletions in Rubinstein-Taybi syndrome patients using real-time quantitative PCR.Hum Mutat. 2004 Mar;23(3):278-84. doi: 10.1002/humu.20001. Hum Mutat. 2004. PMID: 14974086
-
High frequency of mosaic CREBBP deletions in Rubinstein-Taybi syndrome patients and mapping of somatic and germ-line breakpoints.Genomics. 2007 Nov;90(5):567-73. doi: 10.1016/j.ygeno.2007.07.012. Epub 2007 Sep 12. Genomics. 2007. PMID: 17855048
-
Rubinstein-Taybi syndrome: clinical and molecular overview.Expert Rev Mol Med. 2007 Aug 20;9(23):1-16. doi: 10.1017/S1462399407000415. Expert Rev Mol Med. 2007. PMID: 17942008 Review.
-
Diagnosis and management in Rubinstein-Taybi syndrome: first international consensus statement.J Med Genet. 2024 May 21;61(6):503-519. doi: 10.1136/jmg-2023-109438. J Med Genet. 2024. PMID: 38471765 Free PMC article. Review.
Cited by
-
Socio-behavioral characteristics of children with Rubinstein-Taybi syndrome.J Autism Dev Disord. 2009 Sep;39(9):1252-60. doi: 10.1007/s10803-009-0733-4. Epub 2009 Apr 7. J Autism Dev Disord. 2009. PMID: 19350377
-
Characterization of 14 novel deletions underlying Rubinstein-Taybi syndrome: an update of the CREBBP deletion repertoire.Hum Genet. 2015 Jun;134(6):613-26. doi: 10.1007/s00439-015-1542-9. Epub 2015 Mar 25. Hum Genet. 2015. PMID: 25805166 Clinical Trial.
-
Rubinstein-taybi syndrome: a female patient with a de novo reciprocal translocation t(2; 16)(q36.3; p13.3) and dysgranulopoiesis.Clinics (Sao Paulo). 2010;65(1):107-9. doi: 10.1590/S1807-59322010000100016. Clinics (Sao Paulo). 2010. PMID: 20126353 Free PMC article. No abstract available.
-
Rubinstein-Taybi syndrome (CREBBP, EP300).Eur J Hum Genet. 2011 Jan;19(1):preceeding 118-20. doi: 10.1038/ejhg.2010.124. Epub 2010 Jul 28. Eur J Hum Genet. 2011. PMID: 20664634 Free PMC article. No abstract available.
-
Chromosome 16p13.3 Contiguous Gene Deletion Syndrome including the SLX4, DNASE1, TRAP1, and CREBBP Genes Presenting as a Relatively Mild Rubinstein-Taybi Syndrome Phenotype: A Case Report of a Saudi Boy.Case Rep Genet. 2020 Jan 9;2020:6143050. doi: 10.1155/2020/6143050. eCollection 2020. Case Rep Genet. 2020. PMID: 32181026 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Miscellaneous